Table of contents

Inflammatory bowel disease

• Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics (1 October, 2000)

  E A Vasiliauskas, L Y Kam, L C Karp, J Gaiennie, H Yang, S R Targan
• Perceptual responses in patients with inflammatory and functional bowel disease (1 October, 2000)

  L Chang, J Munakata, E A Mayer, M J Schmulson, T D Johnson, C N Bernstein, L Saba, B Naliboff, P A Anton, K Matin
• A simple method for assessing intestinal inflammation in Crohn's disease (1 October, 2000)

  J Tibble, K Teahon, B Thjodleifsson, A Roseth, G Sigthorsson, S Bridger, R Foster, R Sherwood, M Fagerhol, I Bjarnason
• Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low (1 October, 2000)

  R J Farrell, Y Ang, P Kileen, D S O'Briain, D Kelleher, P W N Keeling, D G Weir